
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9538362
[patent_doc_number] => 20140163009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/981107
[patent_app_country] => US
[patent_app_date] => 2012-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51333
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981107
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/981107 | Histone deacetylase inhibitors and compositions and methods of use thereof | Jan 22, 2012 | Issued |
Array
(
[id] => 8940688
[patent_doc_number] => 20130190486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'Method Of Mass Production Of Tetrakis(P-Nitrophenyl)Porphyrins'
[patent_app_type] => utility
[patent_app_number] => 13/354352
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3692
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354352
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/354352 | Method of mass production of tetrakis(p-nitrophenyl)porphyrins | Jan 19, 2012 | Issued |
Array
(
[id] => 9463958
[patent_doc_number] => 20140128385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'BACE-2 INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/979452
[patent_app_country] => US
[patent_app_date] => 2012-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 200876
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979452
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979452 | BACE-2 INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS | Jan 12, 2012 | Abandoned |
Array
(
[id] => 8199380
[patent_doc_number] => 20120122854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Carbocyclic Fused Cyclic Amines'
[patent_app_type] => utility
[patent_app_number] => 13/347820
[patent_app_country] => US
[patent_app_date] => 2012-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18014
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122854.pdf
[firstpage_image] =>[orig_patent_app_number] => 13347820
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/347820 | Carbocyclic Fused Cyclic Amines | Jan 10, 2012 | Abandoned |
Array
(
[id] => 8160347
[patent_doc_number] => 20120101082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'VASOPRESSIN V1A ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/329476
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90747
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101082.pdf
[firstpage_image] =>[orig_patent_app_number] => 13329476
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/329476 | VASOPRESSIN V1A ANTAGONISTS | Dec 18, 2011 | Abandoned |
Array
(
[id] => 8244930
[patent_doc_number] => 08202859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Heterocyclic sulfonamides'
[patent_app_type] => utility
[patent_app_number] => 13/330356
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18626
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202859.pdf
[firstpage_image] =>[orig_patent_app_number] => 13330356
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/330356 | Heterocyclic sulfonamides | Dec 18, 2011 | Issued |
Array
(
[id] => 8664682
[patent_doc_number] => 08378143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-19
[patent_title] => 'Methods of making Efavirens and intermediates thereof'
[patent_app_type] => utility
[patent_app_number] => 13/330381
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9469
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330381
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/330381 | Methods of making Efavirens and intermediates thereof | Dec 18, 2011 | Issued |
Array
(
[id] => 8278504
[patent_doc_number] => 20120172380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'NOVEL 4-(TETRAZOL-5-YL)-QUINAZOLINE DERIVATIVES AS ANTI CANCER AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/330304
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10616
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330304
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/330304 | NOVEL 4-(TETRAZOL-5-YL)-QUINAZOLINE DERIVATIVES AS ANTI CANCER AGENT | Dec 18, 2011 | Abandoned |
Array
(
[id] => 8866868
[patent_doc_number] => 20130150571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'Colored Polysiloxanes'
[patent_app_type] => utility
[patent_app_number] => 13/323747
[patent_app_country] => US
[patent_app_date] => 2011-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9439
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13323747
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/323747 | Colored polysiloxanes | Dec 11, 2011 | Issued |
Array
(
[id] => 8141357
[patent_doc_number] => 20120095229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'CHEMICAL PROCESS'
[patent_app_type] => utility
[patent_app_number] => 13/314034
[patent_app_country] => US
[patent_app_date] => 2011-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22630
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095229.pdf
[firstpage_image] =>[orig_patent_app_number] => 13314034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/314034 | Chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline | Dec 6, 2011 | Issued |
Array
(
[id] => 9198859
[patent_doc_number] => 20130338173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'Carbocycle-Substituted Purine And 7-Deazapurine Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/991145
[patent_app_country] => US
[patent_app_date] => 2011-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62596
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991145
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/991145 | Carbocycle-substituted purine and 7-deazapurine compounds | Dec 4, 2011 | Issued |
Array
(
[id] => 9108332
[patent_doc_number] => 20130281464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'BIGUANIDE DERIVATIVE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/991344
[patent_app_country] => US
[patent_app_date] => 2011-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5738
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991344
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/991344 | Biguanide derivative compound | Nov 30, 2011 | Issued |
Array
(
[id] => 8211933
[patent_doc_number] => 20120130072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'PROCESS FOR THE PREPARATION OF DIHYDROQUINAZOLINES'
[patent_app_type] => utility
[patent_app_number] => 13/308418
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11787
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20120130072.pdf
[firstpage_image] =>[orig_patent_app_number] => 13308418
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/308418 | Process for the preparation of dihydroquinazolines | Nov 29, 2011 | Issued |
Array
(
[id] => 9113308
[patent_doc_number] => 08569482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Nanoparticulate probe for in vivo monitoring of tissue oxygenation'
[patent_app_type] => utility
[patent_app_number] => 13/306565
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 29
[patent_no_of_words] => 34122
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306565
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/306565 | Nanoparticulate probe for in vivo monitoring of tissue oxygenation | Nov 28, 2011 | Issued |
Array
(
[id] => 9095151
[patent_doc_number] => 20130274462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'HIGHLY HEAT-RESISTANT PHTHALOCYANINE'
[patent_app_type] => utility
[patent_app_number] => 13/989082
[patent_app_country] => US
[patent_app_date] => 2011-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12456
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989082
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989082 | Highly heat-resistant phthalocyanine | Nov 21, 2011 | Issued |
Array
(
[id] => 7791628
[patent_doc_number] => 20120053184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'SALTS OF 3-(1H-IND0L-3-YL)-4-[2-(4-METHYL-PIPERAZIN-I-YL)-QUINAZOLIN-4-YL]-PYRROLE-2, 5-DI ONE'
[patent_app_type] => utility
[patent_app_number] => 13/291705
[patent_app_country] => US
[patent_app_date] => 2011-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3029
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053184.pdf
[firstpage_image] =>[orig_patent_app_number] => 13291705
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/291705 | SALTS OF 3-(1H-IND0L-3-YL)-4-[2-(4-METHYL-PIPERAZIN-I-YL)-QUINAZOLIN-4-YL]-PYRROLE-2, 5-DI ONE | Nov 7, 2011 | Abandoned |
Array
(
[id] => 11263233
[patent_doc_number] => 09487520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Coelenterazine derivatives and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 13/287519
[patent_app_country] => US
[patent_app_date] => 2011-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9293
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13287519
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/287519 | Coelenterazine derivatives and methods of using same | Nov 1, 2011 | Issued |
Array
(
[id] => 8484024
[patent_doc_number] => 20120283430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'System and Method for Fluoroalkylated Fluorophthalocyanines With Aggregating Properties and Catalytic Driven Pathway for Oxidizing Thiols'
[patent_app_type] => utility
[patent_app_number] => 13/286393
[patent_app_country] => US
[patent_app_date] => 2011-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 14125
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286393
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/286393 | System and Method for Fluoroalkylated Fluorophthalocyanines With Aggregating Properties and Catalytic Driven Pathway for Oxidizing Thiols | Oct 31, 2011 | Abandoned |
Array
(
[id] => 7784718
[patent_doc_number] => 20120046274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => '6-ALKENYL AND 6-PHENYLALKYL SUBSTITUTED 2-QUINOLINONES AND 2-QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/284110
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22310
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046274.pdf
[firstpage_image] =>[orig_patent_app_number] => 13284110
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/284110 | 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors | Oct 27, 2011 | Issued |
Array
(
[id] => 8725722
[patent_doc_number] => 08404839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-26
[patent_title] => 'Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy} quinazoline difumarate Form A'
[patent_app_type] => utility
[patent_app_number] => 13/273392
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 24
[patent_no_of_words] => 23133
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13273392
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273392 | Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy} quinazoline difumarate Form A | Oct 13, 2011 | Issued |